Oxford Cancer Analytics (OXcan) develops minimally invasive liquid biopsy blood tests for early lung cancer detection using advanced proteomics and AI.

Integrated Biosciences uses synthetic biology and machine learning to develop therapeutics for age-related diseases.

Aperiam Bio is a protein engineering firm that improves protein stability and function through a unique 3D computer vision algorithm, targeting applications in consumer products and pulmonary therapeutics.

DermBiont is a clinical-stage biotechnology company that develops targeted topical therapeutics for dermatological indications, with a focus on treating seborrheic keratoses and melasma.